[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (1,288)

Search Parameters:
Keywords = chemoprevention

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
21 pages, 7550 KiB  
Article
Anticancer and Antioxidant Effects of Bioactive Peptides from Black Soldier Fly Larvae (Hermetia illucens)
by Kwanchanok Praseatsook, Arpamas Vachiraarunwong, Sirinya Taya, Phatthawin Setthaya, Kenji Sato, Hideki Wanibuchi, Rawiwan Wongpoomchai, Pornngarm Dejkriengkraikul, Min Gi and Supachai Yodkeree
Nutrients 2025, 17(4), 645; https://doi.org/10.3390/nu17040645 (registering DOI) - 11 Feb 2025
Viewed by 55
Abstract
Background: Protein hydrolysates from insects are recognized for their biological activities. Black soldier fly larvae (BSFL) have drawn attention due to their antioxidant protein hydrolysates. However, research on bioactive peptides derived from these hydrolysates, particularly their cancer chemopreventive potential, remains limited. This study [...] Read more.
Background: Protein hydrolysates from insects are recognized for their biological activities. Black soldier fly larvae (BSFL) have drawn attention due to their antioxidant protein hydrolysates. However, research on bioactive peptides derived from these hydrolysates, particularly their cancer chemopreventive potential, remains limited. This study aims to evaluate the antioxidant, anti-inflammatory, antimutagenic, and anticancer activities of BSFL-derived bioactive peptides and explore the molecular mechanisms. Methods: Alkali-soluble BSFL protein (ASBP) was extracted and hydrolyzed using Alcalase and bromelain under optimized conditions. Antioxidant activity was assessed via FRAP, ABTS, and DPPH assays. The hydrolysate with the highest antioxidant activity was fractionated into molecular weight (MW) groups (>30, 10, and <3 kDa). The bioactivity of fractionated peptides was evaluated through antioxidant, anti-inflammatory (nitric oxide production in RAW 264.7 cells), antimutagenic (Ames test), and anticancer (CCK-8 assay on HCT 116, COLO205, Cw-2, and Caco-2 cells) assays. Mechanistic insights were obtained via microarray and Western blot analyses. Peptides were identified by LC-MS/MS. Results: The ASBP-Alcalase hydrolysate (ASBP-AH) showed optimal antioxidant activity at 3% (w/w) for 4 h. The ASBP-AH 30 (MW > 30 kDa) fraction exhibited the highest antioxidant capacity. In contrast, the ASBP-AH3 (MW < 3 kDa) fraction exhibited significant antimutagenic effects, reduced nitric oxide production, and decreased COLO205 cell viability. Treatment with ASBP-AH3 at its LC50 dose modulated the SKP2/p21/cyclin D1 pathways. Mostly peptides from ASBP-AH3 were composed of hydrophobic and charged amino acids. Conclusions: BSFL-derived bioactive peptides exhibit potential as multifunctional agents for cancer chemoprevention. In vivo studies are required to explore their clinical applications. Full article
(This article belongs to the Special Issue Bioactive Food Compounds and Human Health)
Show Figures

Figure 1

Figure 1
<p>(<b>A</b>) MW distribution of BSFL and BSFL-H; and (<b>B</b>) MW distribution of ASBP.</p>
Full article ">Figure 2
<p>Antioxidant activities and peptide characteristics of ASBP-H under different enzyme concentrations and incubation times: (<b>A</b>–<b>C</b>) antioxidant activities of ASBP-Alcalase hydrolysates (ASBP-AH) under varying enzyme concentrations (% <span class="html-italic">w</span>/<span class="html-italic">w</span>) and incubation times (h); (<b>D</b>–<b>F</b>) antioxidant activities of ASBP-bromelain hydrolysates (ASBP-BH) under varying enzyme concentrations (% <span class="html-italic">w</span>/<span class="html-italic">w</span>) and incubation times (h); (<b>G</b>–<b>I</b>) effect of ASBP-AH and ASBP-BH combinations on antioxidant hydrolysate production; (<b>J</b>) %DH of individual ASBP-AH and ASBP-BH treatments and their combination; (<b>K</b>) SDS-PAGE analysis using Tris-glycine as the electrode buffer to resolve peptides with high MWs; (<b>L</b>) SDS-PAGE analysis using Tris-tricine as the electrode buffer to resolve peptides with low MWs. Antioxidant activities are expressed as mg Trolox equivalent per gram of extract. Values are presented as mean ± SD (n = 3). Statistical significance determined using one-way ANOVA followed by Duncan’s multiple range test; distinct letters indicate statistically significant differences between groups (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 3
<p>Effects of ASBP-AH peptide fractions on antioxidant and anti-inflammation: The antioxidant activity of ASBP-AH fractions tested by FRAP (<b>A</b>), ABTS (<b>B</b>), and DPPH (<b>C</b>) assay. Antioxidant activities are expressed as mg Trolox equivalent per gram of extract. (<b>D</b>) Anti-inflammatory activities of ASBP-AH and its fractions in 1 μg/mL LPS-induced RAW 264.7 cell lines. Values are presented as mean ± SD (n = 3). Statistical significance determined using one-way ANOVA followed by Duncan’s multiple range test; distinct letters indicate statistically significant differences between groups (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 4
<p>Mutagenic and antimutagenic activity of ASBP-AH peptide fractions: (<b>A</b>,<b>B</b>) Mutagenic activity of ASBP-AH peptide fractions in TA98 strain with (<b>A</b>) or without S9 (<b>B</b>). (<b>C</b>,<b>D</b>) Mutagenic activity in TA100 strain with (<b>C</b>) or without S9 (<b>D</b>). (<b>E</b>,<b>F</b>) Antimutagenic activity of ASBP-AH peptide fractions (1 mg/plate) against mutagens: AFB<sub>1</sub> with S9 and AF-2 without S9 in TA98 strain (<b>E</b>), and MeIQ with S9 and NaN<sub>3</sub> without S9 in TA100 strain (<b>F</b>). The values are expressed as mean ± SD (n = 3). According to a one-way ANOVA with Duncan’s multiple range test, distinct letters indicate statistically significant differences between groups (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 5
<p>Cytotoxicity of ASBP-AH’s fractions: (<b>A</b>–<b>D</b>) %Cell viabilities of ASBP-AH’s fractions on various colon cancer cell lines. (<b>E</b>) %Cell viabilities of fibroblast cell lines. The values are expressed as mean ± SD (n = 3). According to a one-way ANOVA with Duncan’s multiple range test, a distinct letter indicates a statistically significant difference between groups (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 6
<p>Overview of microarray results and protein expression analysis in ASBP-AH3-treated COLO205 cells: (<b>A</b>) the compilation of upregulated (z-score &gt; 2) and downregulated (z-score &lt; −2) pathways identified from the Diseases and Bio Functions dataset following LC<sub>50</sub> treatment of COLO205 cancer cells with ASBP-AH3; (<b>B</b>) the heatmap of log<sub>2</sub>-transformed signal values for inactivated genes from the same dataset; (<b>C</b>) the STRING protein–protein interaction network of inactivated genes from the Diseases and Bio Functions dataset; (<b>D</b>) Western blot analysis; and (<b>E</b>–<b>G</b>) expression ratios of SKP2, p21, and cyclin D1 proteins in the ASBP-AH3-treated group compared to control. Data are presented as mean ± SD (n = 3), with differences between groups determined using Student’s <span class="html-italic">t</span>-test (* <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01).</p>
Full article ">
24 pages, 1000 KiB  
Review
Health Benefits, Applications, and Analytical Methods of Freshly Produced Allyl Isothiocyanate
by Walaa Alibrahem, Duyen H. H. Nguyen, Nihad Kharrat Helu, Florence Tóth, Péter Tamás Nagy, János Posta, József Prokisch and Csaba Oláh
Foods 2025, 14(4), 579; https://doi.org/10.3390/foods14040579 (registering DOI) - 10 Feb 2025
Viewed by 498
Abstract
Allyl isothiocyanate (AITC) is a low-molecular-weight natural chemical predominantly obtained from the autolysis of sinigrin, a glucosinolate found in cruciferous vegetables like mustard, horseradish, and wasabi. AITC has sparked widespread interest due to its various biological actions, which include strong antioxidant, anti-inflammatory, antibacterial, [...] Read more.
Allyl isothiocyanate (AITC) is a low-molecular-weight natural chemical predominantly obtained from the autolysis of sinigrin, a glucosinolate found in cruciferous vegetables like mustard, horseradish, and wasabi. AITC has sparked widespread interest due to its various biological actions, which include strong antioxidant, anti-inflammatory, antibacterial, and anticancer capabilities. This compound offers promising potential in several fields, particularly in food preservation, medicine, and enhancing food quality through natural means. AITC’s effectiveness against a broad spectrum of microorganisms, including foodborne pathogens and spoilage agents, makes it an attractive natural alternative to synthetic preservatives. The potential to extend the shelf life of perishable foods makes AITC an important tool for food production, meeting rising customer demand for natural additives. In addition to its antimicrobial effects, AITC demonstrates significant anti-inflammatory activity, reducing levels of pro-inflammatory cytokines and modulating key signaling pathways, which could make it valuable in managing chronic inflammatory conditions. Furthermore, emerging research highlights its potential in cancer prevention and treatment, as AITC has been demonstrated to induce apoptosis and inhibit cell increase in several cancer cell lines, offering a natural approach to chemoprevention. This review delves into the chemical structure, metabolism, and bioavailability of freshly produced AITC, providing a comprehensive overview of its beneficial properties. Challenges related to AITC’s volatility, dosage optimization, and regulatory considerations are also discussed, alongside future research directions to enhance the stability and efficacy of AITC-based formulations. The findings underscore AITC’s role as a versatile bioactive compound with known potential to support human health and the sustainable food industry. Full article
(This article belongs to the Section Food Nutrition)
Show Figures

Figure 1

Figure 1
<p>Sinigrin is converted enzymatically into AITC, glucose, and sulfate.</p>
Full article ">Figure 2
<p>When cells are activated by pro-inflammatory stimuli, IκB kinase (IKK) undergoes activation. This activation allows NF-κB to enter the nucleus, where it starts the transcript of different pro-inflammatory genes (TNF-a, iNOS, Cox-2, IL-6, and IL-1β). NF-kB-P65 activation is inhibited by AITC which leads to a decreasing number of various pro-inflammatory cytokines. AITC: Allyl isothiocyanate. NF-κB: Nuclear factor kappa-light-chain-enhancer of activated B cells. TNFα: Tumor necrosis factor-alpha. IKK: IκB kinase. IL-6: Interleukin-6. IL-1β: Interleukin-1 beta. COX-2: Cyclooxygenase-2.</p>
Full article ">Figure 3
<p>Schematic diagram of the molecular mechanisms for anticancer activity of AITC. AITC is known to exert anticancer effects by stimulating apoptosis or the interplay among G2/M phase arrest. ROS production induced by AITC fully facilitates mitochondrial apoptotic mechanisms. Blockage of G2/M phase by AITC occurs by modulating Wee1, Chk1, and CDK1/cyclin B signal molecules. AITC, allyl isothiocyanate; ROS, reactive oxygen species; <span class="html-italic">Bcl-2</span>, B cell lymphoma 2; <span class="html-italic">Bax</span>, Bcl2-associated X protein; Cdc2, cyclin-dependent kinase 1; Chk1, checkpoint kinase 1; Apaf-1, apoptotic protease activating factor1; Wee1, a protein kinase.</p>
Full article ">
29 pages, 7628 KiB  
Review
Fifty Years of Aflatoxin Research in Qidong, China: A Celebration of Team Science to Improve Public Health
by Jian-Guo Chen, Yuan-Rong Zhu, Geng-Sun Qian, Jin-Bing Wang, Jian-Hua Lu, Thomas W. Kensler, Lisa P. Jacobson, Alvaro Muñoz and John D. Groopman
Toxins 2025, 17(2), 79; https://doi.org/10.3390/toxins17020079 (registering DOI) - 9 Feb 2025
Viewed by 544
Abstract
The Qidong Liver Cancer Institute (QDLCI) and the Qidong Cancer Registry were established in 1972 with input from doctors, other medical practitioners, and non-medical investigators arriving from urban centers such as Shanghai and Nanjing. Medical teams were established to quantify the extent of [...] Read more.
The Qidong Liver Cancer Institute (QDLCI) and the Qidong Cancer Registry were established in 1972 with input from doctors, other medical practitioners, and non-medical investigators arriving from urban centers such as Shanghai and Nanjing. Medical teams were established to quantify the extent of primary liver cancer in Qidong, a corn-growing peninsula on the north side of the Yangtze River. High rates of liver cancer were documented and linked to several etiologic agents, including aflatoxins. Local corn, the primary dietary staple, was found to be consistently contaminated with high levels of aflatoxins, and bioassays using this corn established its carcinogenicity in ducks and rats. Observational studies noted a positive association between levels of aflatoxin in corn and incidence of liver cancer across townships. Biomarker studies measuring aflatoxin B1 and its metabolite aflatoxin M1 in biofluids reflected the exposures. Approaches to decontamination of corn from aflatoxins were also studied. In 1993, investigators from Johns Hopkins University were invited to visit the QDLCI to discuss chemoprevention studies in some townships. A series of placebo-controlled clinical trials were conducted using oltipraz (a repurposed drug), chlorophyllin (an over-the-counter drug), and beverages prepared from 3-day-old broccoli sprouts (rich in the precursor phytochemical for sulforaphane). Modulation of biomarkers of aflatoxin DNA and albumin adducts established proof of principle for the efficacy of these agents in enhancing aflatoxin detoxication. Serendipitously, by 2012, aflatoxin exposures quantified using biomarker measurements documented a many hundred-fold reduction. In turn, the Cancer Registry documents that the age-standardized incidence rate of liver cancer is now 75% lower than that seen in the 1970s. This reduction is seen in Qidongese who have never received the hepatitis B vaccination. Aflatoxin mitigation driven by economic changes switched the dietary staple of contaminated corn to rice coupled with subsequent dietary diversity leading to lower aflatoxin exposures. This 50-year effort to understand the etiology of liver cancer in Qidong provides the strongest evidence for aflatoxin mitigation as a public health strategy for reducing liver cancer burden in exposed, high-risk populations. Also highlighted are the challenges and successes of international team science to solve pressing public health issues. Full article
(This article belongs to the Section Mycotoxins)
Show Figures

Figure 1

Figure 1
<p>Timeline for the founding and achievements of the Qidong Liver Cancer Institute with regard to their studies on the etiologic role of aflatoxins in the high incidence and mortality of liver cancer in this region. IARC, International Agency for Research on Cancer; AFB-alb, aflatoxin-albumin adduct biomarker; HCC, hepatocellular carcinoma.</p>
Full article ">Figure 2
<p>(<b>A</b>) Qidong County Government document on the establishment of “Qidong Liver Cancer Research Leadership Group” (1972). Headers in red: “Documents of the Revolutionary Committee of Qidong County DRCQC (1972) No. 189. Quotations from Chairman Mao: China should make a greater contribution to mankind. (<b>B</b>) Dormitory and working rooms of “medical team members” in Qidong (early 1970s). (<b>C</b>) Research building of the Qidong Liver Cancer Institute (2002). (<b>D</b>) Liver Cancer Research Experimental Duck Farm next to the Yellow Sea of Qidong (late 1970s).</p>
Full article ">Figure 3
<p>Duck liver cancer and its cytoarchitecture. (<b>Left</b>): A mallard duck with liver cancer from a group fed with aflatoxin-containing moldy corn. (<b>Right</b>): Duck hepatocellular carcinoma with trabecular arrangement and visible blood vessels.</p>
Full article ">Figure 4
<p>(<b>Left</b>). Members of the Medical Team discussing the prevention and treatment of liver cancer with local “Barefoot Doctors” at Jianghai District Hospital, Qidong (1974). (<b>Right</b>). Qidong researcher working with the “Medical Team” members at the Qidong Mold Lab (1973). Photos courtesy of Jian-Guo Chen.</p>
Full article ">Figure 5
<p>Visit of Johns Hopkins scientists to the Qidong Liver Cancer Institute (September 1993). (<b>Left</b> to <b>right:</b>) Drs. Lu-Yi Yu, John Groopman, Thomas Kensler, Nancy Davidson, Yuan-Rong Zhu, Geng-Sun Qian, and Bao-Chu Zhang. Photo credit: Jian-Guo Chen.</p>
Full article ">Figure 6
<p>Transport of clinical trial materials to Qidong by ferry (1995). (<b>A</b>) Supplies initially shipped to the Shanghai Cancer Institute. (<b>B</b>) Overnight ferry from Shanghai to Qidong. (<b>C</b>) Off-loading supplies by handcart. (<b>D</b>) One of many community meetings led by Dr. Chen to explain the clinical trial and recruit participants for the screening phase of the study. (<b>E</b>) Satellite view of the Yangtze River Basin area of China. Photo credits: Thomas Kensler.</p>
Full article ">Figure 7
<p>Oltipraz Chemoprevention Trial (1995). (<b>A</b>) ”Prevention is Best, Health First” (”yùfáng wéi zhǔ, jiànkāng dì yī”) calendar presenting the synchronous structure of the trial for participants. (<b>B</b>) The Daxin Medical Clinical where screening and follow-up were conducted. (<b>C</b>) Drs. Jacobson and Qian reviewing eligibility questionnaires. Photo credits: Thomas Kensler.</p>
Full article ">Figure 8
<p>Collecting and processing overnight urine samples for biomarker analyses. (<b>A</b>) Adding ascorbate to urine collection containers. (<b>B</b>) Receiving and organizing overnight voids from study participants. (<b>C</b>) Measuring urine volumes and aliquoting samples for freeze-down at the local ”urinarium.” Photo credits: Thomas Kensler.</p>
Full article ">Figure 9
<p>Preparing glucoraphanin-rich broccoli sprout beverage at the Qidong Liver Cancer Institute. (<b>A</b>) Building sprouting racks. (<b>B</b>) Cleaning the ”greenhouse”: Jed Fahey and Patricia Egner. (<b>C</b>) Watering the sprouts every other hour for 3 days. (<b>D</b>) Boiling 3-day-old sprouts to make the beverage: Justin Fahey. The first brew was the treatment beverage; a fourth brew of the broccoli mash became the placebo. There was no glucoraphanin (or other inducer activity) in the placebo. Photo credits: Thomas Kensler.</p>
Full article ">Figure 10
<p>(<b>Top left</b>) Early visit to the Qidong Cancer Registry by Dr. Alvaro Muñoz with Drs. Kensler, Jian-Guo Chen, and Tao-Yang Chen (<b>Bottom left</b>). Caligraphy for “Friendship Cooperation” (“Yŏuyì Hézuò”) by J-G Chen—Hézuò is also the township where the first broccoli sprout beverage trial was conducted. (<b>Right</b>) “Cancer in Qidong, China”, a comprehensive summary of the Qidong Cancer Registry 1972–2011 edited by Jian-Guo Chen [<a href="#B11-toxins-17-00079" class="html-bibr">11</a>]. Photo credits: Thomas Kensler.</p>
Full article ">Figure 11
<p>Fifty-year tracking of the age standardized rates for liver and lung cancer incidence in Qidong by gender. Data from the Qidong Cancer Registry.</p>
Full article ">Figure 12
<p>Decline in age-standardized incidence of liver cancer in Qidong with percentages of residents with detectable serum aflatoxin-albumin adducts collected between 1995 and 2012 (<span class="html-italic">N</span> = 100 for each year). Adapted from references [<a href="#B9-toxins-17-00079" class="html-bibr">9</a>,<a href="#B86-toxins-17-00079" class="html-bibr">86</a>]. <span class="html-italic">Inset:</span> drying corn, corn porridge, and household stored corn in rural Qidong (early 1990s) and a sign in a Qidong city park encouraging dietary diversity titled “Balanced Dietary Pagoda for Chinese Residents” (2012). Photo credits: Thomas Kensler.</p>
Full article ">Figure 13
<p>Last clinical trial team in Qidong (2018). The COVID pandemic and closed borders subverted ongoing and future field studies. (<b>Left</b> to <b>right</b>): Jin-Bing Wang, Jian-Hua Lu, Jian-Guo Chen, John Groopman, Thomas Kensler, Yuan-Rong Zhu, Patricia Egner, Geng-Sun Qian, Jian Zhu.</p>
Full article ">Figure 14
<p>Using biomarkers and a cancer registry, Qidong research brings light to reduction of aflatoxin-induced liver cancer. Photo credit: Caroline Kensler.</p>
Full article ">
22 pages, 2894 KiB  
Review
Nicotinamide: A Multifaceted Molecule in Skin Health and Beyond
by Lara Camillo, Elisa Zavattaro and Paola Savoia
Medicina 2025, 61(2), 254; https://doi.org/10.3390/medicina61020254 - 1 Feb 2025
Viewed by 794
Abstract
Nicotinamide (NAM), the amide form of vitamin B3, is a precursor to essential cofactors nicotinamide adenine dinucleotide (NAD⁺) and NADPH. NAD⁺ is integral to numerous cellular processes, including metabolism regulation, ATP production, mitochondrial respiration, reactive oxygen species (ROS) management, DNA repair, cellular senescence, [...] Read more.
Nicotinamide (NAM), the amide form of vitamin B3, is a precursor to essential cofactors nicotinamide adenine dinucleotide (NAD⁺) and NADPH. NAD⁺ is integral to numerous cellular processes, including metabolism regulation, ATP production, mitochondrial respiration, reactive oxygen species (ROS) management, DNA repair, cellular senescence, and aging. NAM supplementation has demonstrated efficacy in restoring cellular energy, repairing DNA damage, and inhibiting inflammation by suppressing pro-inflammatory cytokines release. Due to its natural presence in a variety of foods and its excellent safety profile—even at high doses of up to 3 g/day—NAM is extensively used in the chemoprevention of non-melanoma skin cancers and the treatment of dermatological conditions such as blistering diseases, atopic dermatitis, rosacea, and acne vulgaris. Recently, its anti-aging properties have elevated NAM’s prominence in skincare formulations. Beyond DNA repair and energy replenishment, NAM significantly impacts oxidative stress reduction, cell cycle regulation, and apoptosis modulation. Despite these multifaceted benefits, the comprehensive molecular mechanisms underlying NAM’s actions remain not fully elucidated. This review consolidates recent research to shed light on these mechanisms, emphasizing the critical role of NAM in cellular health and its therapeutic potential. By enhancing our understanding, this work underscores the importance of continued exploration into NAM’s applications, aiming to inform future clinical practices and skincare innovations. Full article
(This article belongs to the Section Dermatology)
Show Figures

Figure 1

Figure 1
<p>Pathways for NAD<sup>+</sup> synthesis in mammalian cells. In mammalian cells, NAD<sup>+</sup> can be synthesized from NA through the Preiss–Haidler pathway or de novo from tryptophan. However, most NAD<sup>+</sup> is recycled via the salvage pathway from NAM. NAD, nicotinamide adenine dinucleotide; NMN, nicotinamide mononucleotide; NAMN, nicotinic acid mononucleotide; NAAD, nicotinic acid adenine dinucleotide; NADS, NAD synthetase; NMNAT, nicotinamide mononucleotide adenylyl transferase; NAMPT, nicotinamide phosphoribosyl transferase; NAPRT, nicotinic acid phosphorybosiltransferase; Urh1, uridine hydrolase; Meu1, methylthioadenosine phosphorylase; Pnp1, purine nucleoside phosphorylase; NRK, nicotinamide riboside kinase.</p>
Full article ">Figure 2
<p>Schematic representation of NAM metabolism. Oral ingested NAM is absorbed in the small intestine through simple or facilitated diffusion, reaching the liver where excess NAM is metabolized by cytochrome P450 NAM into 4-PYR and 2-PYR, which are excreted. NAM, nicotinamide; CYP450, cytochrome P450; N-Ox, nicotinamide N-oxide; MNA, N-methyl-nicotinamide; 4-PYR, N1- methyl-4-pyridone-3-carboxamide; 2-PYR, N1-methyl-2-pyridone-5-carboxamide.</p>
Full article ">Figure 3
<p>Representation of the electromagnetic spectrum emitted by the sun. UVC is known for its germicidal properties since it can seriously damage RNA and DNA of bacteria and fungi [<a href="#B125-medicina-61-00254" class="html-bibr">125</a>]. UVB catalyzes the reactions of vitamin D synthesis, in particular between 290 and 315 nm (280 nm wavelength is absorbed by the atmosphere), but is also responsible for acute and chronic effects, including skin carcinogenesis [<a href="#B126-medicina-61-00254" class="html-bibr">126</a>,<a href="#B127-medicina-61-00254" class="html-bibr">127</a>]. UVA is widely used in clinics for phototherapy but also accelerates skin aging and indirectly contributes to cancer development [<a href="#B128-medicina-61-00254" class="html-bibr">128</a>].</p>
Full article ">
17 pages, 2163 KiB  
Article
The Chemopreventive Effect of Ginsenoside Compound K Is Regulated by PARP-1 Hyperactivation, Which Is Promoted by p62-Dependent SIRT6 Degradation
by Sang-Hun Kim, Sung-Hwan Ki, Seok-Woo Hyeong and Seon-Hee Oh
Nutrients 2025, 17(3), 539; https://doi.org/10.3390/nu17030539 - 31 Jan 2025
Viewed by 381
Abstract
Background and aims: Ginsenoside compound K (CK), a saponin metabolite of ginseng, exerts anticancer effects; however, its molecular mechanisms of action in lung cancer remain unclear. We investigated the involvement of silent information regulator 6 (SIRT6) and poly (ADP-ribose) polymerase 1 (PARP-1) in [...] Read more.
Background and aims: Ginsenoside compound K (CK), a saponin metabolite of ginseng, exerts anticancer effects; however, its molecular mechanisms of action in lung cancer remain unclear. We investigated the involvement of silent information regulator 6 (SIRT6) and poly (ADP-ribose) polymerase 1 (PARP-1) in the anticancer effects of CK in lung cancer. Methods and Results: CK induced PARP-1 activation-mediated parthanatos via sequestosome-1/p62-mediated SIRT6 degradation and inhibited the proliferation of H460 cells. Although CK reduced procaspase-8 levels, no significant apoptotic cleavage of procaspase-3 or PARP-1 was observed. Furthermore, CK upregulated p27, p21, phospho-p53, and gamma-H2AX levels. CK increased LC3-II levels in a p62-independent manner, but p62 was upregulated by autophagy inhibition, indicating that p62 is involved in CK-induced autophagy. CK-treated cells showed typical features of parthanatos, including PARP-1 hyperactivation, intracellular redistribution of poly ADP-ribose and pro-apoptotic factors, and chromatin fragmentation. SIRT6 was degraded in a CK concentration- and time-dependent manner. SIRT6 protein was upregulated by PARP-1 inhibition, nicotinamide adenine dinucleotide (NAD)+ supplementation, antioxidants, and p62 knockdown, but was decreased by autophagy blockade. PARP-1 activation was negatively correlated with SIRT6 levels, indicating that SIRT6 and PARP-1 activation play complementary roles in CK-induced growth inhibition. Immunofluorescence staining, fractionation studies, and immunoprecipitation were used to confirm the colocalization and interaction between p62 and SIRT6. Conclusions: PARP-1 activation is promoted by p62-mediated SIRT6 degradation, which plays an important role in CK-induced growth inhibition. Therefore, SIRT6 is a potential biomarker for the chemopreventive effect of CK in lung cancer cells, but further studies on SIRT6 are needed for the clinical application of CK. Full article
(This article belongs to the Special Issue Natural Active Substances and Cancer)
Show Figures

Figure 1

Figure 1
<p>CK induced morphological changes and cell proliferation inhibition. (<b>A</b>) H460 cell morphological changes after the exposure to increasing CK concentrations for up to 24 h monitored by phase-contrast microscopy. Arrows and red asterisk denote the cytoplasmic vacuoles and floating cells, respectively. (<b>B</b>) Cells were treated as outlined in A, and cell viability was determined using an MTT assay. Data are expressed as the mean ± SD. * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.005. (<b>C</b>,<b>D</b>) Cells were exposed for 18 h in ascending order of CK concentration or for up to 24 h with a CK concentration of 35 µg/mL. Lysates were analyzed based on immunoblotting. β-actin was used as a loading control (<span class="html-italic">n</span> &gt; 3).</p>
Full article ">Figure 2
<p>CK induced parthanatos and SIRT6 protein degradation. (<b>A</b>) H460 cells were exposed for 18 h in ascending order of CK concentration or for up to 24 h with a CK concentration of 35 µg/mL. Lysates were analyzed based on immunoblotting. β-actin was used as a loading control (<span class="html-italic">n</span> &gt; 3). (<b>B</b>) H460 cells cultured on coverslips were exposed to CK for 18 h, fixated, and the nuclei were stained with Hoechst 33342. Arrows indicate the parthanatos nuclear features. Images were taken using a fluorescence microscope (×200). (<b>C</b>) Cells were exposed to CK for 6, 12, and 18 h and subsequently performed intracellular fractionation into insoluble (nuclear enriched membrane), cytosolic, and particulate (mitochondrial enriched) fractions. The enrichment of each fraction was assessed via immunoblotting for HDAC1, β-actin, and SOD2 (<span class="html-italic">n</span> &gt; 3). (<b>D</b>) Cells were exposed to CK for 18 h after a pretreatment with 3-AB, ANI, zVAD-fmk, or dimethylsulfoxide (DMSO) control for 2 h. Lysates were analyzed using immunoblotting for the indicated proteins. β-actin was used as the loading control. (<b>E</b>,<b>F</b>) Cells were exposed to increasing NAD+ concentrations (25 and 50 nM) for 18 h after pretreatment and then to CK. Immunoblotting was used to analyze the levels of the indicated proteins. Cells were cultured for 24 h as outlined in E, and cell viability was measured using MTT. Data are presented as mean ± SD. * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.005.</p>
Full article ">Figure 3
<p>SIRT6 negatively regulates PARP-1 activation by CK. (<b>A</b>) Immunoblotting was used to evaluate the knockdown efficiency of Sirt6-specific siRNA. NC = negative control. (<b>B</b>) H460 cells infected with NC or Sirt6 siRNA were challenged with CK for 18 h and the levels of the shown proteins were assayed using immunoblotting (<span class="html-italic">n</span> = 3). (<b>C</b>) Morphological changes in cells treated as in B were viewed with phase-contrast microscopy. Arrows represent cytoplasmic vacuoles. (<b>D</b>) After 24 h of transfection with an empty vector or pcDNA3.1-Sirt6, immunoblotting for SIRT6 was performed. (<b>E</b>,<b>F</b>) Cells overexpressing SIRT6 were treated with 35 µg/mL of CK for 18 h, observed for morphological changes, and then harvested and lysed. Immunoblotting was used to analyze the levels of the indicated proteins. β-actin was taken as a loading control. Arrows indicate the cytoplasmic vacuoles. Scale bar = 25 µm.</p>
Full article ">Figure 4
<p>Oxidative stress and autophagy regulate CK-induced PARP-1 activation and SIRT6 protein stability. (<b>A</b>) H460 cells were exposed for 18 h in ascending order of CK concentration or for up to 24 h with a CK concentration of 35 µg/mL. Lysates were analyzed based on immunoblotting. (<b>B</b>) Cells were exposed to CK a maximum of 8 h and were stained with JC-1 dye. Images were captured under a fluorescence microscope. Scale bar = 25 µm. (<b>C</b>) Cells were pretreated with NAC (5 mM) or tocopherol (25 µM) for 2 h and then continuously treated with CK for 18 h. Immunoblotting was used to analyze the levels of the indicated proteins (<span class="html-italic">n</span> ≥ 3). (<b>D</b>) After culturing cells treated as described in C for 24 h, the viability was determined using the MTT assay. Data are expressed as the mean ± SD. # <span class="html-italic">p</span> &lt; 0.001; *** <span class="html-italic">p</span> &lt; 0.0005. (<b>E</b>) Cells were pretreated with BaF1 (100 nM), CQ (50 µM), and DMSO for 2 h and then exposed to CK for 18 h. The lysates were subjected to immunoblotting for the indicated proteins. (<b>F</b>,<b>G</b>) The knockdown efficiency obtained using ATG5-specific siRNA was evaluated using immunoblotting for ATG5. NC = negative control. Cells knocked down with NC or ATG5 siRNA were exposed to CK (35 µg/mL) for 18 h and the levels of each protein were assayed using immunoblotting. β-actin was taken as a loading control (<span class="html-italic">n</span> = 3).</p>
Full article ">Figure 5
<p>The subcellular translocation of SIRT6 depends on p62. (<b>A</b>) The indicated proteins were analyzed in the subcellular fraction samples obtained in <a href="#nutrients-17-00539-f002" class="html-fig">Figure 2</a>C. (<b>B</b>,<b>C</b>) Immunoblotting for p62 was performed to assess the knockdown efficiency of the p62-specific siRNA. NC = negative control. Cells transfused with NC or p62 siRNA were incubated with CK (35 µg/mL) for 18 h. The shown proteins were assayed by immunoblotting. β-actin was taken as a loading control (<span class="html-italic">n</span> = 3). (<b>D</b>) Cells grown on coverslips were transfected with NC or p62 siRNA, exposed to CK for 12 h, fixed, and performed IF immunostaining for both SIRT6 (red) and p62 (green). Nuclei were counterstained with Hoechst 33342 (blue). The yellow arrows indicate p62 in the perinuclear region. Scale bar, 25 µm.</p>
Full article ">Figure 6
<p>SIRT6 can interact with p62 through its ubiquitination. (<b>A</b>) H460 cells were pretreated with LMB (25 nm) or DMSO for 2 h and then continuously treated with CK for 18 h. (<b>B</b>) Cells were harvested and subjected to intracellular fractionation into insoluble (nuclear enriched membrane), cytosolic, and microparticulate fractions. Enrichment of individual fractions was measured using immunoblotting for HDAC1 (nucleus), β-actin (cytosol), SOD2 (mitochondria), LC3-II (autophagosome), and calnexin (endoplasmic reticulum) (<span class="html-italic">n</span> &gt; 3). (<b>C</b>) Cells grown on coverslips were treated with DMSO or LMB (25 nm) for 2 h, continuously exposed to CK for 12 h, fixed, and performed IF staining for SIRT6 (red) and p62 (green). Nuclei were counterstained by Hoechst 33342 (blue). Scale bar, 25 µm. (<b>D</b>,<b>E</b>) Cells were exposed to CK (30 µg/mL) for 12 h, lysates were immunoblotted for SIRT6, and 800 µg of the residual protein was used for IP assays using p62, ubiquitin (Ub), and mouse IgG antibodies, followed by immunoblotting for SIRT6 (<span class="html-italic">n</span> = 2).</p>
Full article ">Figure 7
<p>Schematic diagram of CK-induced PARP-1 activation and its regulatory mechanism.</p>
Full article ">
20 pages, 10426 KiB  
Article
Molecular Docking Study and 3D-QSAR Model for Trans-Stilbene Derivatives as Ligands of CYP1B1
by Zbigniew Dutkiewicz and Renata Mikstacka
Int. J. Mol. Sci. 2025, 26(3), 1002; https://doi.org/10.3390/ijms26031002 - 24 Jan 2025
Viewed by 338
Abstract
Scientific research on stilbenes is conducted for their chemopreventive and therapeutic properties. In experimental studies, natural and synthetic trans-stilbenes exhibit antioxidant, anti-inflammatory, cardioprotective, and anticancer effects. The antitumor activity of some natural and synthetic stilbenes is associated with their interaction with cytochrome P450 [...] Read more.
Scientific research on stilbenes is conducted for their chemopreventive and therapeutic properties. In experimental studies, natural and synthetic trans-stilbenes exhibit antioxidant, anti-inflammatory, cardioprotective, and anticancer effects. The antitumor activity of some natural and synthetic stilbenes is associated with their interaction with cytochrome P450 family 1, which leads to the inhibition of procarcinogen activation. In the present study, three-dimensional quantitative structure–activity relationship analysis (3D-QSAR) was performed on a series of forty-one trans-stilbene derivatives to identify the most significant features of the molecules responsible for their CYP1B1 inhibitory activity. The developed 3D-QSAR model presented a cross-validated correlation coefficient Q2 of 0.554. The model’s predictive ability was confirmed by external validation (r2 = 0.808). The information provided by 3D-QSAR analysis is expected to be valuable for the rational design of novel CYP1B1 inhibitors. Full article
Show Figures

Figure 1

Figure 1
<p>Alignment of the data set molecules for conformations generated by CDOCKER. Superimposed molecules are presented as stick models with gray carbon, red oxygen, yellow sulfur, and white hydrogen atoms.</p>
Full article ">Figure 2
<p>Plot of predicted vs. experimental values of pIC<sub>50</sub> for the training set (filled circles) and test set (empty circles).</p>
Full article ">Figure 3
<p>Williams plot for applicability domain of the 3D-QSAR model (training set—filled circles; test set—empty circles).</p>
Full article ">Figure 4
<p>Electrostatic contour maps for 3Q-QSAR model with (<b>A</b>) compound <b>1</b> and (<b>B</b>) compound <b>41</b> aligned. Ligands are represented as stick models with black carbon, red oxygen, and white hydrogen atoms. Red and blue contours represent regions that favor high-electron-density and low-electron-density groups, respectively.</p>
Full article ">Figure 5
<p>Steric contour maps for 3D-QSAR model with (<b>A</b>) compound <b>1</b> and (<b>B</b>) compound <b>41</b> aligned. Ligands are represented as stick models with black carbon, red oxygen, and white hydrogen atoms. Green and yellow contours represent regions where the presence of bulky groups may increase and decrease activity, respectively.</p>
Full article ">Figure 6
<p>Steric field of 3D-QSAR model and amino acids constituting CYP1B1 binding site. Yellow areas responsible for unfavorable steric interactions are surrounded by amino acids depicted as yellow sticks; those represented as green sticks are adjacent to the green contour, where groups with steric bulk enhance activity. The remaining amino acids forming the binding site are shown as lines with gray carbon, red oxygen, blue nitrogen and white hydrogen atoms.</p>
Full article ">Figure 7
<p>Ligands directed towards heme with (<b>A</b>) 4-monosubstituted, (<b>B</b>) 3,4-disubstituted, (<b>C</b>) unsubstituted, (<b>D</b>) 2,4-disubstituted, (<b>E</b>) 2,3-disubstituted or 3-monosubstituted, and (<b>F</b>) 3,5-disubstituted ring. Heme is shown as a stick model in blue.</p>
Full article ">Figure 8
<p>Heat map of CYP1B1–ligand interactions, representing number of compound interactions with a given residue: amino acid or heme (Hem900). The number of interactions with residue is color-coded: the minimum value (no interaction) is blue, the maximum (five interactions) is marked in red, and values from 1 to 4 are represented by colors from cyan to orange.</p>
Full article ">Figure 9
<p>Interactions of ligand <b>35</b> with amino acids and heme: (<b>A</b>) 3D representation; (<b>B</b>) 2D diagram.</p>
Full article ">
23 pages, 3918 KiB  
Article
Bioassays to Assess the Safety of Potassium and Sodium Nitrates and Nitrites
by Tania Merinas-Amo, Rocío Merinas-Amo, Laura Márquez Prados, Rafael Font, Mercedes Del Río Celestino and Ángeles Alonso-Moraga
Processes 2025, 13(2), 325; https://doi.org/10.3390/pr13020325 - 24 Jan 2025
Viewed by 494
Abstract
(1) Background: Advances in food processing practices and health care are some of the most significant advances in modern daily life. The goal of this study is to evaluate the safety of potassium and sodium nitrates and nitrites when they are used as [...] Read more.
(1) Background: Advances in food processing practices and health care are some of the most significant advances in modern daily life. The goal of this study is to evaluate the safety of potassium and sodium nitrates and nitrites when they are used as fertilizers in agriculture and food additives, as well as the known conversion of nitrate to nitrite in humans. (2) Methods: Various bioassays were conducted to investigate the effects of nitrates and nitrites in the Drosophila melanogaster genetic tester system. These assays focused on the modulation of degenerative processes at the molecular, cellular, individual, and population levels. Additionally, we assessed the chemopreventive potential and the ability to induce DNA strand breaks in HL-60 tumour cells. (3) Results: All nitrate and nitrite concentrations tested were shown to not be toxic or genotoxic in Drosophila since none of the compounds reached the LD50 and significant genetic mutation. A positive or null protective capacity against a toxic agent was found for nitrates, not for nitrites, showing that sodium nitrite has a synergistic effect when combined with the oxidant toxin hydrogen peroxide; and a nutraceutical potential in the lifespan only for sodium nitrate to improve the quality of life in 5 days at ADI concentration. The in vitro results in human leukemia cells showed a chemopreventive potential only for potassium nitrate and sodium nitrite due to reducing the viability of HL-60 cells growth to 18% and 29%, respectively, compared to the controls at ADI (acceptable daily intake) concentrations. However, neither of these showed DNA damage or methylation modifications. (4) Conclusions: The tested compounds were shown to be safe to use during in vivo and in vitro tests when used at the extrapolated ADI concentrations. Full article
Show Figures

Figure 1

Figure 1
<p>Toxicity levels of potassium and sodium nitrites and nitrates in <span class="html-italic">D. melanogaster</span>. Values represent the percentage mean of surviving adults ± SD from three independent experiments. Letters mean significant differences with respect to the H<sub>2</sub>O control; chi-square value is higher than 5.02 (<span class="html-italic">p</span> ≤ 0.05). The numbers 1 through 6 represent the various dilutions tested (refer to <a href="#processes-13-00325-t001" class="html-table">Table 1</a> for details).</p>
Full article ">Figure 2
<p>Antitoxicity levels of potassium and sodium nitrites and nitrates in <span class="html-italic">D. melanogaster.</span> Values represent the percentage mean of surviving adults ± SD from three independent combined experiments. Letters mean significant differences with respect to the H<sub>2</sub>O<sub>2</sub> control; the chi-square value is higher than 5.02 with respect to the positive control (<span class="html-italic">p</span> ≤ 0.05). The numbers 1 through 6 represent the various dilutions tested (refer to <a href="#processes-13-00325-t001" class="html-table">Table 1</a> for details).</p>
Full article ">Figure 3
<p>Longevity results of <span class="html-italic">D. melanogaster</span> fed with different concentrations of potassium and sodium nitrite and nitrate. Survival curves were generated using the Kaplan–Meier method, and statistical significance was evaluated using the log-rank method (Mantel–Cox). The numbers 1 through 6 represent the various dilutions tested (refer to <a href="#processes-13-00325-t001" class="html-table">Table 1</a> for details).</p>
Full article ">Figure 4
<p>Effects of potassium and sodium nitrite and nitrate on HL-60 cells growth. Values represent the viability mean ± SD of treated HL-60 cells from three independent experiments. The numbers 1 through 6 represent the various dilutions tested (refer to <a href="#processes-13-00325-t001" class="html-table">Table 1</a> for details). ≠ scale break.</p>
Full article ">Figure 5
<p>Internucleosomal DNA fragmentation in HL-60 cells treated with different concentrations of nitrites and nitrates. M: DNA size marker; C: negative control treatment; the numbers 1 through 6 represent the various dilutions tested (refer to <a href="#processes-13-00325-t001" class="html-table">Table 1</a> for details).</p>
Full article ">Figure 6
<p>DNA single- or double-strand break inductions in HL-60 cells treated with Ppotassium and sodium nitrite and nitrate. DNA migrations are reported as mean TM values. The experimental setup included the following: (<b>a</b>) positive control, cells treated with a compound known to induce DNA damage [<a href="#B52-processes-13-00325" class="html-bibr">52</a>]; (<b>b</b>) negative control, untreated cells; (<b>c</b>,<b>d</b>) Alkaline comet assay (pH &lt; 13) of HL-60 cells treated with the tested nitrites and nitrates at the acceptable daily intake (ADI) concentration (see <a href="#processes-13-00325-t001" class="html-table">Table 1</a>). The single cell parameters observed in the images below were estimated using the OpenComet plugging from ImageJ (NIH).</p>
Full article ">Figure 7
<p>Methylation status of potassium and sodium nitrite and nitrate in HL-60 cells. Values represent the relative normalized expression mean of each repetitive element ± SE from three independent experiments. * significant <span class="html-italic">p</span> ≤ 0.05, respect to the control. Number 3 indicates the dilution tested for each substance (see <a href="#processes-13-00325-t001" class="html-table">Table 1</a>).</p>
Full article ">
3 pages, 1757 KiB  
Correction
Correction: Hao et al. Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice. Biomolecules 2024, 14, 105
by Qiongyu Hao, Susanne M. Henning, Clara E. Magyar, Jonathan Said, Jin Zhong, Matthew B. Rettig, Jaydutt V. Vadgama and Piwen Wang
Biomolecules 2025, 15(2), 160; https://doi.org/10.3390/biom15020160 - 21 Jan 2025
Viewed by 361
Abstract
The authors would like to replace Figure 3B of the following published paper [...] Full article
Show Figures

Figure 3

Figure 3
<p>Enhanced prostate tumorigenesis inhibition by combining GT, Q, and Arc. Prostate-specific PTEN knockout mice (3 weeks old, <span class="html-italic">n</span> = 10 per group) were administered with GT+Q (GT as drinking water + 0.2% Q in diet), Arc (30 mg/kg of body weight daily via oral gavage), GT+Q+Arc, or control until 16 weeks of age. Tumor development was monitored through in vivo imaging every 3 weeks. (<b>A</b>) Study flow chart. Representative images are shown in (<b>B</b>) and results in (<b>C</b>). Food (<b>D</b>) and water (<b>E</b>) consumption was measured 3 times a week, and mouse body weight (<b>F</b>) once a week. Data are presented as mean ± SD. Con, control; GT, green tea; Q, quercetin, Arc: arctigenin. Different letters at each time point indicate a significant difference between groups, <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">
16 pages, 3190 KiB  
Article
Nutrient–Nutrient Interactions Among Broccoli Glucosinolates and Their Implications for Breeding Cruciferous Crops to Enhance Human Health
by Weston Bussler, Katelyn DeZego, Holli Chandler, Robert W. Reid and Slavko Komarnytsky
Nutrients 2025, 17(2), 344; https://doi.org/10.3390/nu17020344 - 18 Jan 2025
Viewed by 754
Abstract
While a balanced diet can fulfill most nutritional needs, optimizing the composition of specific foods like broccoli can amplify their health benefits. Background/Objectives: Broccoli (Brassica oleracea L. Italica group) is a widely consumed cruciferous vegetable valued for its gastrointestinal and immune health [...] Read more.
While a balanced diet can fulfill most nutritional needs, optimizing the composition of specific foods like broccoli can amplify their health benefits. Background/Objectives: Broccoli (Brassica oleracea L. Italica group) is a widely consumed cruciferous vegetable valued for its gastrointestinal and immune health benefits. However, the individual contributions and interactions of broccoli glucosinolates, as they hydrolyze into bioactive isothiocyanates, remain poorly understood. Methods: This study investigated mixtures of four major aliphatic glucosinolates—glucoraphanin, gluconapin, progoitrin, and sinigrin—in individual and combinational models to assess their effects on human colorectal cell proliferation. Results: Combination index analysis revealed moderate to strong antagonistic interactions among these glucosinolates, with the most significant antagonism observed during enzymatic hydrolysis by myrosinase. Mixture analysis identified an optimal glucosinolate ratio including glucoraphanin (81–84%), gluconapin (9–19%), and others (0–7%) to maximize their antiproliferative effects (adjusted R2 > 0.80). This optimal profile was achievable within the target broccoli mapping population. Testing the near-optimal VB067 isogenic broccoli line showed a 44% increase in antiproliferative activity compared to the initial breeding parent or an average sister line. Conclusions: This study highlights the potential of leveraging nutrient–nutrient interactions to guide molecular breeding and produce functional varieties of cruciferous vegetables with optimized health benefits. Full article
(This article belongs to the Special Issue Nutritional Value and Health Benefits of Dietary Bioactive Compounds)
Show Figures

Figure 1

Figure 1
<p>Schematic pathway and structural relationships among the aliphatic glucosinolates. The compounds used in this study are in bold, and their respective isothiocyanates are in red. There are multiple enzymatic steps between homomethionine or dihomomethionine and the respective metabolites (abbreviated as multiple arrows).</p>
Full article ">Figure 2
<p>Schematic diagrams indicating the experimental setups to produce (<b>a</b>) individual hydrolysis (IND), combined hydrolysis (COMB), and pooled hydrolysis (MIX) of broccoli aliphatic glucosinolates in the presence of myrosinase, and (<b>b</b>) the augmented simplex-centroid mixture design model to evaluate glucosinolate–glucosinolate interactions at the level of myrosinase and their effect on the antiproliferative qualities in the human colorectal adenocarcinoma cells.</p>
Full article ">Figure 3
<p>Antiproliferative effects of aliphatic glucosinolates from broccoli. HT-29 human colon cancer cells were treated with 0.5–50 μM myrosinase-hydrolyzed glucosinolates to establish the corresponding IC<sub>50</sub> values for individual compounds.</p>
Full article ">Figure 4
<p>Mixture contour plots using a tetrahedral projection of (<b>a</b>) combined COMB and (<b>b</b>) pooled MIX hydrolysis of broccoli glucosinolates tested at 50 μM. The potency of antiproliferative effects against HT-29 cells is shown as a color gradient from gray (lowest) to red (highest). Arrows indicate the direction of the decreasing proportion for each individual glucosinolate in the mixture. Lateral panels were inverted to maintain the correct tetrahedral projections.</p>
Full article ">Figure 5
<p>Total glucosinolate profile (<b>a</b>) and the profile change (<b>b</b>) of two selected broccoli isogenic lines with an average (VB019) and a near-optimal (VB067) profile identified in this study. All glucosinolates including aliphatic glucoraphanin (GR), gluconapin (GN), progoitrin (PG), glucoiberin (GIB), sinigrin (SGN), aromatic glucobrassicin (GB), neoglucobrassicin (NGB), and indolic gluconasturitiin (GNT) were quantified by HPLC. The data were analyzed using one-way ANOVA followed by Dunnett’s multiple comparisons, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 6
<p>Antiproliferative effects of two selected broccoli isogenic lines with an average (VB019) and near-optimal (VB067) profile identified in this study as compared to the commercial parent line (VI-158) and a reference drug (paclitaxel at 10 µM). HT-29 human colon cancer cells were treated with myrosinase-hydrolyzed whole broccoli floret extracts. The data were analyzed using one-way ANOVA followed by Dunnett’s multiple comparisons, *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">
30 pages, 2960 KiB  
Review
A Review of Potential Agents for Colon Cancer Interception in FAP Patients: Evidence from Preclinical Studies in APCMin/+ Mice
by Karthikkumar Venkatachalam, Krishnendu Goswami, Venkateshwar Madka and Chinthalapally V. Rao
Targets 2025, 3(1), 4; https://doi.org/10.3390/targets3010004 - 17 Jan 2025
Viewed by 792
Abstract
Colorectal cancer (CRC) is one of the major reasons for cancer-related deaths around the world. Constitutive activation of WNT pathway, due to APC gene mutation, is the characteristic feature of most human colon tumors. Familial adenomatous polyposis (FAP) patients inherit APC mutations and [...] Read more.
Colorectal cancer (CRC) is one of the major reasons for cancer-related deaths around the world. Constitutive activation of WNT pathway, due to APC gene mutation, is the characteristic feature of most human colon tumors. Familial adenomatous polyposis (FAP) patients inherit APC mutations and pose an absolute risk of developing CRC in their lifetime. The genetically modified APC mouse models have paved the way to study various aspects of the hereditary human CRC, including biochemical, molecular, and histological aspects. Preclinical and clinical data suggest that certain dietary supplements, NSAIDs, natural products, and chemically synthesized compounds, can help in intercepting CRC incidence and progression by modulating various hallmarks of cancer. In this review, we have provided a summary of promising natural and synthetic agents that demonstrated chemopreventive efficacy against CRC in the FAP-mimicking APCMin/+ mouse model. Full article
Show Figures

Figure 1

Figure 1
<p>The analysis of co-occurrence and visualization provides valuable insights to find the study clusters and explore the new research trend (<b>A</b>,<b>B</b>). In VOSviewer, the co-occurrence frequencies are calculated based on the keywords provided by the authors in the literature database. The authors used 3067 keywords in 1218 screened documents. Co-occurrence = 5, 110 keywords in total. (Source: <a href="http://pubmed.gov" target="_blank">pubmed.gov</a>; search string “Natural products and colon cancer”; from 2014 to 2024).</p>
Full article ">Figure 2
<p>Schematic representation for some important pathways and proteins involved in the hallmarks of colon cancer in APC mice.</p>
Full article ">
27 pages, 2977 KiB  
Article
Evaluation of the Antioxidant Properties and Bioactivity of Koroneiki and Athinolia Olive Varieties Using In Vitro Cell-Free and Cell-Based Assays
by Maria Gkasdrogka, Fotios Tekos, Zoi Skaperda, Periklis Vardakas and Demetrios Kouretas
Int. J. Mol. Sci. 2025, 26(2), 743; https://doi.org/10.3390/ijms26020743 - 16 Jan 2025
Viewed by 553
Abstract
Olive oil and table olives are considered staples of the Mediterranean diet and have been associated with various health benefits. Literature reports that the final composition of the olive drupe is greatly affected by varietal and agronomic factors, each contributing to a different [...] Read more.
Olive oil and table olives are considered staples of the Mediterranean diet and have been associated with various health benefits. Literature reports that the final composition of the olive drupe is greatly affected by varietal and agronomic factors, each contributing to a different degree. To that end, the objective of the study was the evaluation of the contribution of different agronomic conditions applied to two Greek olive varieties (Koroneiki, Mastoidis) using a holistic approach of in vitro methods. The findings highlight the importance of the application of a combination of agronomic techniques for each variety, as marked by the differences found in the antioxidant radical-scavenging and reducing power assays. Furthermore, the results obtained from the measurement of redox biomarkers (GSH, ROS, TBARS) in cell lines (EA.hy926, HepG2, MKN45) treated with olive samples demonstrate the capacity of the samples to induce redox imbalance, either by protecting normal cells from damage, or by inducing oxidative damage in cancer cell lines, with the Athinolia samples exhibiting greater antioxidant potential at lower concentrations. This particular finding could have further applications in possible chemo-preventive approaches facilitated by antioxidant compounds of natural origins. Full article
(This article belongs to the Special Issue Insights into Redox Homeostasis and Oxidative Stress)
Show Figures

Figure 1

Figure 1
<p>Heat map of the antioxidant score, corresponding to the antioxidant potential of Greek olive samples for the assays DPPH•, ABTS<sup>•+</sup>, Superoxide radical (O<sub>2</sub><sup>•−</sup>), Hydroxyl radical (OH•), Reducing power (RP), and Peroxyl radical (ROO•)-induced plasmid DNA relaxation assay. The color scale from gray to white represents the Antioxidant score values of the normalized antioxidant capacity data, from low to high, respectively, with 0 representing the lowest antioxidant score and 1 the highest.</p>
Full article ">Figure 2
<p>Heat map of the antioxidant score, corresponding to the antioxidant potential of Athinolia samples for the assays DPPH•, ABTS<sup>•+</sup>, Superoxide radical (O<sub>2</sub><sup>•−</sup>), Hydroxyl radical (OH•), Reducing power (RP), and Peroxyl radical (ROO•)-induced plasmid DNA relaxation assay. (Grove 2: rainfed, 630 m, Grove 3: rainfed, 270 m, Grove 4: irrigated, 270 m). The color scale from gray to white represents the Antioxidant score values of the normalized antioxidant capacity data, from low to high, respectively, with 0 representing the lowest antioxidant score and 1 the highest.</p>
Full article ">Figure 3
<p>Heat map of the antioxidant score, corresponding to the antioxidant potential of Athinolia samples for the assays DPPH•, ABTS<sup>•+</sup>, Superoxide radical (O<sub>2</sub><sup>•−</sup>), Hydroxyl radical (OH•), Reducing power (RP), and Peroxyl radical (ROO•)-induced plasmid DNA relaxation assay, with respect to the altitude (Grove 2: 630 m, Grove 3: 270 m). The color scale from gray to white represents the Antioxidant score values of the normalized antioxidant capacity data, from low to high, respectively, with 0 representing the lowest antioxidant score and 1 the highest.</p>
Full article ">Figure 4
<p>Heat map of the antioxidant score, corresponding to the antioxidant potential of Athinolia samples for the assays DPPH•, ABTS<sup>•+</sup>, Superoxide radical (O<sub>2</sub><sup>•−</sup>), Hydroxyl radical (OH•), Reducing power (RP), and Peroxyl radical (ROO•)-induced plasmid DNA relaxation assay, with respect to the irrigation regime (Grove 3: rainfed, Grove 4: irrigated). The color scale from gray to white represents the Antioxidant score values of the normalized antioxidant capacity data, from low to high, respectively, with 0 representing the lowest antioxidant score and 1 the highest.</p>
Full article ">Figure 5
<p>Heat map of the antioxidant score, corresponding to the antioxidant potential of Koroneiki samples for the assays DPPH•, ABTS<sup>•+</sup>, Superoxide radical (O<sub>2</sub><sup>•−</sup>), Hydroxyl radical (OH•), Reducing power (RP), and Peroxyl radical (ROO•)-induced plasmid DNA relaxation assay (Grove 1: rainfed, 580 m, Grove 5: irrigated, 152 m). The color scale from gray to white represents the Antioxidant score values of the normalized antioxidant capacity data, from low to high, respectively, with 0 representing the lowest antioxidant score and 1 the highest.</p>
Full article ">Figure 6
<p>Heat map of the antioxidant score, corresponding to the antioxidant potential of Greek olive samples for the assays DPPH•, ABTS<sup>•+</sup>, Superoxide radical (O<sub>2</sub><sup>•−</sup>), Hydroxyl radical (OH•), Reducing power (RP), and Peroxyl radical (ROO•)-induced plasmid DNA relaxation assay, with respect to different irrigation regimes. The color scale from grey to white represents the Antioxidant score values of the normalized antioxidant capacity data, from low to high, respectively, with 0 representing the lowest antioxidant score and 1 the highest.</p>
Full article ">Figure 7
<p>Heat map of the antioxidant score, corresponding to the antioxidant potential of Greek olive samples for the assays DPPH•, ABTS<sup>•+</sup>, Superoxide radical (O<sub>2</sub><sup>•−</sup>), Hydroxyl radical (OH•), Reducing power (RP), and Peroxyl radical (ROO•)-induced plasmid DNA relaxation assay, with respect to the altitude. The color scale from gray to white represents the Antioxidant score values of the normalized antioxidant capacity data, from low to high, respectively, with 0 representing the lowest antioxidant score and 1 the highest.</p>
Full article ">Figure 8
<p>Heat map of the effects of olive samples on the levels of GSH, ROS, and TBARS on EA.hy926 cells, in comparison to the control untreated cells. The color scale from gray to white represents the percentage change of control values, from low to high, respectively, with gray representing lower values and white higher.</p>
Full article ">Figure 9
<p>Heat map of the effects of olive samples on the levels of GSH, ROS, and TBARS on HepG2 cells, in comparison to the control untreated cells. The color scale from gray to white represents the percentage change of control values, from low to high, respectively.</p>
Full article ">Figure 10
<p>Heat map of the effects of olive samples on the levels of GSH, ROS and TBARS on MKN-45 cells, in comparison to the control untreated cells. The color scale from gray to white represents the percentage change of control values, from low to high, respectively.</p>
Full article ">
29 pages, 575 KiB  
Review
Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention Strategies
by Eliza Del Fiol Manna, Davide Serrano, Laura Cazzaniga, Sara Mannucci, Cristina Zanzottera, Francesca Fava, Gaetano Aurilio, Aliana Guerrieri-Gonzaga, Matilde Risti, Mariarosaria Calvello, Irene Feroce, Monica Marabelli, Cecilia Altemura, Lucio Bertario, Bernardo Bonanni and Matteo Lazzeroni
Genes 2025, 16(1), 82; https://doi.org/10.3390/genes16010082 - 13 Jan 2025
Viewed by 1127
Abstract
Women carrying pathogenic/likely pathogenic (P/LP) variants in moderate- or high-penetrance genes have an increased risk of developing breast cancer. However, most P/LP variants associated with breast cancer risk show incomplete penetrance. Age, gender, family history, polygenic risk, lifestyle, reproductive, hormonal, and environmental factors [...] Read more.
Women carrying pathogenic/likely pathogenic (P/LP) variants in moderate- or high-penetrance genes have an increased risk of developing breast cancer. However, most P/LP variants associated with breast cancer risk show incomplete penetrance. Age, gender, family history, polygenic risk, lifestyle, reproductive, hormonal, and environmental factors can affect the expressivity and penetrance of the disease. However, there are gaps in translating how individual genomic variation affects phenotypic presentation. The expansion of criteria for genetic testing and the increasing utilization of comprehensive genetic panels may enhance the identification of individuals carrying P/LP variants linked to hereditary breast cancer. Individualized risk assessment could facilitate the implementation of personalized risk-reduction strategies for these individuals. Preventive interventions encompass lifestyle modifications, chemoprevention, enhanced surveillance through breast imaging, and risk-reducing surgeries. This review addresses the current literature’s inconsistencies and limitations, particularly regarding risk factors and the intensity of preventive strategies for women with P/LP variants in moderate- and high-penetrance genes. In addition, it synthesizes the latest evidence on risk assessment and primary and secondary prevention in women at high risk of breast cancer. Full article
(This article belongs to the Section Human Genomics and Genetic Diseases)
16 pages, 681 KiB  
Review
Exploring Chemoprevention in Colorectal Cancer for Patients with Inflammatory Bowel Disease: Mechanisms of Action and Clinical Aspects
by Fotios S. Fousekis, Konstantinos Mpakogiannis, Panagiotis Filis, Alexandros Skamnelos, Dimitrios K. Christodoulou, Davide Mauri and Konstantinos H. Katsanos
Cancers 2025, 17(2), 229; https://doi.org/10.3390/cancers17020229 - 12 Jan 2025
Viewed by 1047
Abstract
Background: Inflammatory bowel diseases (IBDs) have been associated with a higher risk of colorectal cancer (CRC) development and chronic colonic inflammation seems to have a critical role in the pathogenesis of CRC in patients suffering from IBD. In respect to that, surveillance colonoscopy [...] Read more.
Background: Inflammatory bowel diseases (IBDs) have been associated with a higher risk of colorectal cancer (CRC) development and chronic colonic inflammation seems to have a critical role in the pathogenesis of CRC in patients suffering from IBD. In respect to that, surveillance colonoscopy at regular intervals is recommended in patients with colitis. Objective: This review aims to explore the chemopreventive potential of a range of agents, including mesalazine, thiopurines, anti-TNF agents, statins, ursodeoxycholic acid, aspirin, folic acid, and nutraceuticals. Results: These agents target inflammation, oxidative stress, and oncogenic pathways, thereby offering the potential to reduce the risk of CRC in patients with IBD. Anti-TNF agents, such as infliximab and adalimumab, not only reduce colonic inflammation, but also play a protective role against CRC by lessening the carcinogenic effects associated with prolonged inflammatory processes. Furthermore, mesalazine and thiopurines have demonstrated established efficacy, while newer biologics, including interleukin inhibitors, show promising advancements. Although nutraceuticals and dietary interventions require further clinical validation, they offer additional possibilities for non-pharmacological prevention. Conclusion: Despite progress, knowledge gaps persist regarding the long-term safety, optimal dosing, and combined use of these agents. A significant reduction in the incidence of CRC in patients with IBD could be achieved by advancing chemoprevention and personalizing strategies. Full article
(This article belongs to the Special Issue Advanced Research in Oncology in 2024)
Show Figures

Figure 1

Figure 1
<p>Colonoscopy surveillance in IBD patients according to ECCO guidelines [<a href="#B28-cancers-17-00229" class="html-bibr">28</a>]. If possible, surveillance should be performed during disease remission. * In patients who have no colonic involvement or a disease limited to the rectum, no further IBD-specific surveillance is indicated; ** Including post liver transplant; *** In patients who have not undergone surgery.</p>
Full article ">
11 pages, 703 KiB  
Article
Current Enzooticity of Dirofilaria immitis and Angiostrongylus vasorum in Central and Southern Italy
by Donato Traversa, Simone Morelli, Angela Di Cesare, Chiara Astuti, Alessandra Barlaam, Mariasole Colombo, Fabrizia Veronesi, Barbara Paoletti, Raffaella Iorio, Raffaella Maggi, Alessandra Passarelli, Alessia Pede, Linda Rossi and Manuela Diaferia
Animals 2025, 15(2), 172; https://doi.org/10.3390/ani15020172 - 10 Jan 2025
Viewed by 794
Abstract
Dirofilaria immitis and Angiostrongylus vasorum are major parasitic nematodes of dogs. Many environmental and phenological changes have recently modified their geographic patterns in many countries; thus, this study has updated the distribution of D. immitis and A. vasorum in dog populations of selected [...] Read more.
Dirofilaria immitis and Angiostrongylus vasorum are major parasitic nematodes of dogs. Many environmental and phenological changes have recently modified their geographic patterns in many countries; thus, this study has updated the distribution of D. immitis and A. vasorum in dog populations of selected regions of Central and Southern Italy. Also, collateral data on other endoparasites affecting the study population have been collected. Blood and fecal samples collected from 2000 dogs were tested using Knott’s test and copromicroscopy (i.e., Baermann’s and fecal flotation tests), respectively. Binomial logistic regression was performed to evaluate statistically significant associations between positivity for D. immitis and/or A. vasorum and potential risk factors. Overall, 35 (1.7%) and 62 (3.1%) dogs were positive for microfilariae of D. immitis and first stage larvae (L1) of A. vasorum, respectively, while 3 (0.1%) were co-infected by both nematodes. Microfilariae of Dirofilaria repens were found in 148 (7.4%) dogs, while at the flotation, eggs of Ancylostomatidae, Trichuris vulpis, and ascarids were found in the feces of 323 (16.5%), 249 (12.4%), and 172 (8.6%), dogs, respectively. Overall, 217 (10.8%) and 44 (2.2%) dogs were positive for eggs of Capillaria aerophila and Capillaria boehmi. The presence of cardiorespiratory clinical signs or non-specific signs, history of travel, and an age of >4 years old were significantly associated with positivity for D. immitis, while A. vasorum was significantly recorded in dogs with cardiorespiratory signs, or with a history of mollusk ingestion or permanent outdoor housing. These results confirm that D. immitis is enzootic in the investigated regions of Central and Southern Italy, even where it was rare/undetected until recently. Indeed, although some dogs positive for D. immitis had a history of travel in enzootic areas, the majority of them were never moved, indicating that they acquired the parasite in the region where they live. Additionally, A. vasorum is stably enzootic in the study areas, as also are other extraintestinal nematodes (i.e., D. repens and C. aerophila) that are more frequently detected today than in the past. A high level of vigilance and routine parasitological screening are necessary, considering the high prevalence of intestinal parasites in owned dogs that are also co-infected by respiratory parasites. The implementation of chemoprevention against D. immitis in dogs living in the examined area should be encouraged. Full article
(This article belongs to the Section Companion Animals)
Show Figures

Figure 1

Figure 1
<p>Study sites and distribution of dogs positive for <span class="html-italic">Dirofilaria immitis</span> and <span class="html-italic">Angiostrongylus vasorum</span> in the present study. Light-grey spots indicate the specific areas of sampling within the regions.</p>
Full article ">
44 pages, 3456 KiB  
Review
Species Differences in the Biotransformation of Aflatoxin B1: Primary Determinants of Relative Carcinogenic Potency in Different Animal Species
by David L. Eaton, David E. Williams and Roger A. Coulombe
Toxins 2025, 17(1), 30; https://doi.org/10.3390/toxins17010030 - 9 Jan 2025
Viewed by 744
Abstract
It has been known since the early days of the discovery of aflatoxin B1 (AFB1) that there were large species differences in susceptibility to AFB1. It was also evident early on that AFB1 itself was not toxic but required bioactivation to a reactive [...] Read more.
It has been known since the early days of the discovery of aflatoxin B1 (AFB1) that there were large species differences in susceptibility to AFB1. It was also evident early on that AFB1 itself was not toxic but required bioactivation to a reactive form. Over the past 60 years there have been thousands of studies to delineate the role of ~10 specific biotransformation pathways of AFB1, both phase I (oxidation, reduction) and phase II (hydrolysis, conjugation, secondary oxidations, and reductions of phase I metabolites). This review provides a historical context and substantive analysis of each of these pathways as contributors to species differences in AFB1 hepatoxicity and carcinogenicity. Since the discovery of AFB1 as the toxic contaminant in groundnut meal that led to Turkey X diseases in 1960, there have been over 15,000 publications related to aflatoxins, of which nearly 8000 have addressed the significance of biotransformation (metabolism, in the older literature) of AFB1. While it is impossible to give justice to all of these studies, this review provides a historical perspective on the major discoveries related to species differences in the biotransformation of AFB1 and sets the stage for discussion of other papers in this Special Issue of the important role that AFB1 metabolites have played as biomarkers of exposure and effect in thousands of human studies on the toxic effects of aflatoxins. Dr. John Groopman has played a leading role in every step of the way—from initial laboratory studies on specific AFB1 metabolites to the application of molecular biomarkers in epidemiological studies associating dietary AFB1 exposure with liver cancer, and the design and conduct of chemoprevention clinical trials to reduce cancer risk from unavoidable aflatoxin exposures by alteration of specific AFB1 biotransformation pathways. This article is written in honor of Dr. Groopman’s many contributions in this area. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Basic steps in the oxidation of AFB1 to various metabolites. The human enzymes, where known, catalyzing these oxidations are listed. Each oxidation step shown in <a href="#toxins-17-00030-f001" class="html-fig">Figure 1</a> is discussed in detail below, with a focus on understanding important species differences in each oxidation step, as well as the specific enzyme isoforms that contribute to each reaction.</p>
Full article ">Figure 2
<p>Hepatic microsomal oxidation of AFB1 to various oxidative metabolites in different species. The initial rates of formation (Vo) were determined in hepatic microsomes from rat, mouse, monkey, and human microsomes under identical experimental conditions. AFBO was determined by trapping as the GSH conjugate using BHA-induced mouse liver cytosol, which contains a high level of mGSTA3-3. Each metabolite was separated and quantitated by HPLC. Rates of AFBO formation as a percentage of that observed with rat liver microsomes are also shown. The rates of formation of AFQ1, AFM1, and AFP1 were calculated as a percentage of the rate of epoxidation observed for the respective species; these values are shown above each column. (From Ramsdell and Eaton [<a href="#B16-toxins-17-00030" class="html-bibr">16</a>]). Reprinted under AACR copyright permissions to authors.</p>
Full article ">Figure 3
<p>AFB1 metabolite distribution at 1 μM and 10 μM in mouse, rat, and human hepatocytes. Isolated hepatocytes from each species were incubated for 4 h in cell culture medium. Metabolites were identified by HPLC-MS/MS. (From: Gerdemann et al. [<a href="#B6-toxins-17-00030" class="html-bibr">6</a>]; figure is reprinted under Creative Commons Attribution 4.0 International License).</p>
Full article ">Figure 4
<p>Immuno-inhibition experiments using anti-peptide antiserum against turkey P450s 1A5 and 3A37 demonstrating the relative contribution of P450 1A5 and 3A37 toward AFB1 epoxidation in turkey liver microsomes. Inhibitory effects of anti-P450 1A5 and 3A37 immune serum (5 μg/mL/nmol P450). Initial rates of exo-AFBO formation in the presence of antiserum were calculated as percentage control (treatment with pre-immune serum only). Mean ± SD. (N = 3). From: Rawl and Coulombe, [<a href="#B85-toxins-17-00030" class="html-bibr">85</a>]. Reprinted under Open Access Creative Commons Attribution.</p>
Full article ">Figure 5
<p>Phase II hydrolysis and conjugation reactions of phase I oxidation products of AFB1 biotransformation.</p>
Full article ">Figure 6
<p>Effects of co-expression of human mEH on AFB-DNA adducts in yeast also co-expressing hCYP1A2 to activate AFB1 to AFBO. Two concentrations of AFB1 were used to expose yeast cells containing human CYP1A2 and mEH cDNAs (adapted from Kelly et al. [<a href="#B138-toxins-17-00030" class="html-bibr">138</a>]. * Co-expression of mEH blocked DNA adduction with significant effect (<span class="html-italic">p</span> &lt; 0.05) at 1.25 mM AFB. Data are mean 6 SEM from samples analyzed in triplicate. (Figure available under Creative Commons Attribution 4.0 International license).</p>
Full article ">Figure 7
<p>Modulation of AFB-DNA adduct formation in the context of the GSTM1 genotype status. A total of 11 different hepatocyte preparations were examined for AFB-DNA binding. Six of the samples were GSTM1-null and five were GSTM1-positive. AFB-DNA adducts per 10<sup>7</sup> nucleotides were calculated and are shown. Each bar represents the mean and SEM. Statistical significance was determined by unpaired <span class="html-italic">t</span>-test with equal variances. Adapted from: Gross-Steinmeyer et al. [<a href="#B157-toxins-17-00030" class="html-bibr">157</a>]. Reprinted with permission from Oxford Press, Oxford, UK OX2 6DP; license #5923750542730, 7 December 2024.</p>
Full article ">Figure 8
<p>AFB-DNA adduct formation in mGstA3 knockout mice and wild-type. Mice (5 mGstA3 KO and 5 WT, 6 months of age, all males) were injected with a single dose of 5 mg/kg AFB1, dissolved in DMSO, in a volume of 100 μL/30 g of mouse weight, and euthanized 3 h later. Redrawn from: Ilic et al. [<a href="#B173-toxins-17-00030" class="html-bibr">173</a>], with permission from Elsevier Press, Berkeley, CA; license # 5923751463839, 7 December 2024.</p>
Full article ">Figure 9
<p>Reverse-phase HPLC radiochromatograms of cytosolic GST conjugation of AFBO in mouse and turkey. The top panel shows [<sup>3</sup>H]-AFBO-GST activity of BHA-induced mouse liver cytosol (500 mg protein) for comparison. The middle panel show the lack of GST-mediated [<sup>3</sup>H]-AFBO-conjugating ability of turkey hepatic cytosol (1200 mg protein). A control incubation with no cytosol is also presented (bottom panel). Even when a wide range of turkey cytosolic protein concentrations (400–1200 mg) was used, no GST-mediated trapping was detected [<a href="#B78-toxins-17-00030" class="html-bibr">78</a>]. Reprinted with permission from Elsevier Press, Berkeley, CA 94704, license # 5923770700438, 7 December 2024.</p>
Full article ">Figure 10
<p>Timeline of research interest in aflatoxins, as indicated by the number of scientific publications each year from 1963 to December 2024. Data from a PubMed search on the term “aflatoxin” or “aflatoxins”.</p>
Full article ">Figure 11
<p>Publication and citation history of Dr. John Groopman’s contributions to the past 45 years of aflatoxin research, including many papers related to species differences in biotransformation. (Figure developed from data obtained from a Web of Science citation search on “John D. Groopman” and “aflatoxins”).</p>
Full article ">
Back to TopTop